Technetium [99mTc]-H7ND injection

DRUG2 trials

Sponsors

Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd.

Conditions

Peritoneal MetastasisSolid Tumor

Phase 1

Technetium [99mTc]-H7ND in Patients With Gastrointestinal Malignancies and Healthy Volunteers

CompletedNCT06443710

Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd.Solid Tumor

Start: 2024-05-14End: 2024-11-19Updated: 2025-07-15

Phase 2

A Phase II Clinical Study to Evaluate the Efficacy and Safety of Technetium [99mtc]-H7ND Injection in the Diagnosis of Peritoneal Metastasis of Gastrointestinal Malignant Tumor.

RecruitingNCT07107633

Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd.Peritoneal Metastasis, Solid Tumor

Start: 2025-03-12End: 2025-09-30Target: 90Updated: 2025-08-06